1. Home
  2. ATLO vs SLS Comparison

ATLO vs SLS Comparison

Compare ATLO & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$26.35

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$5.47

Market Cap

706.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
SLS
Founded
1903
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.2M
706.7M
IPO Year
2001
2007

Fundamental Metrics

Financial Performance
Metric
ATLO
SLS
Price
$26.35
$5.47
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
34.7K
5.4M
Earning Date
04-24-2026
04-16-2026
Dividend Yield
2.93%
N/A
EPS Growth
8.03
62.69
EPS
0.38
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$70.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$0.95
52 Week High
$28.35
$5.66

Technical Indicators

Market Signals
Indicator
ATLO
SLS
Relative Strength Index (RSI) 47.43 69.64
Support Level $19.47 $1.48
Resistance Level $28.28 N/A
Average True Range (ATR) 0.62 0.46
MACD -0.26 0.11
Stochastic Oscillator 19.14 91.10

Price Performance

Historical Comparison
ATLO
SLS

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: